Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Heavy Metals (Cadmium, Lead, Mercury, Zinc), Angiogenesis Factors (Endostatin, Angiostatin, VEGF) and Osteopontin in Patients With Coronary Artery Disease

NCT02159235 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT02159235
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02159235 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Heavy Metals (Cadmium, Lead, Mercury, Zinc), Angiogenesis Factors (Endostatin, Angiostatin, VEGF) and Osteopontin in Patients With Coronary Artery Disease
Lead sponsor
Medical University of Vienna
Phase
Observational
Overall status
Completed
Start date
September 30, 2010
Completion date
April 30, 2013
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, heavy metal toxicity, ischemic heart disease